Dr. Mehrad Abedi, MD

Dr. Abedi practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Abedi's NPI, 1467459222, was assigned on July 7, 2005. Dr. Abedi holds California license C53685.

Dr. Abedi's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Abedi's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Abedi is also affiliated with Renown Regional Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Abedi to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abedi practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Abedi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Abedi is licensed in California.

CMS data shows 885 Medicare services from Dr. Abedi across 9 procedure codes in 2024, for 170 Medicare patients. Medicare paid $69,333 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 170 Medicare patients who saw Dr. Abedi in 2024. The largest group is 65 to 74, with 84 patients. 71% of them have high blood pressure, and 64% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abedi's median patient age at 64, with 43% women.

In 2024, Dr. Abedi wrote 202 Medicare Part D claims for 39 patients. 84% of them were for generic drugs. CMS names the drug for 94 of them, across 3 drugs with 11 or more claims each, at $29,951 in total drug cost. In 2023, CMS named 88 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Abedi for performance year 2024, reported as part of a group. Dr. Abedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abedi as offering telehealth.

CMS Open Payments shows 649 general payments to Dr. Abedi from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Kite Pharma, Inc. paid the most, $224,247. It also lists 3 research payments totaling $2,968 from 2016 to 2017.